Checkpoint Therapeutics diskutieren
Checkpoint Therapeutics
WKN: A2JAHK / Symbol: CKPT / Name: Checkpoint Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,50 €
-
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $76.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at LADENBURG THALM/SH SH from $96.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at Lake Street Capital from $32.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at LADENBURG THALM/SH SH from $65.00 to $47.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at Cantor Fitzgerald from $19.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at Lake Street Capital from $16.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at B. Riley from $8.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at HC Wainwright from $34.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for CKPT provided by MarketBeat
Neueste Beiträge
StockNews_com in Ampio Pharmaceuticals Inc. diskutieren